- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SMG buys Ziegler refurbishing center
Ziegler Medical Equipment has completed its exit from operatingits own equipment refurbishing business by selling its Omaha refurboperation to Shared Medical Equipment Group, also of Omaha. Ziegler president Thomas Norman announced last month that
Ziegler Medical Equipment has completed its exit from operatingits own equipment refurbishing business by selling its Omaha refurboperation to Shared Medical Equipment Group, also of Omaha.
Ziegler president Thomas Norman announced last month that Zieglerhad decided to scale back its investment in refurbishing equipmentdue to aggressive OEM price slashing on new equipment, which wascutting into used equipment sales. The West Bend, WI, companyhalted its effort to enlarge its direct sales force for refurbishedequipment and said it was in negotiations to sell its Omaha refurbishingcenter (SCAN 7/31/96). Ziegler will continue to sell pre-ownedequipment.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
